Julie Kanter, MD, on Highest Priorities for Sickle Cell After Gene Therapy Approvals
The director of the Adult Sickle Cell Clinic and associate professor at University of Alabama Birmingham pointed out access to a sickle cell specialist as one such priority.
Julie Kanter, MD, on Developing Recommendations for SCD Post Gene Therapy
The director of the Adult Sickle Cell Clinic and associate professor at University of Alabama Birmingham discussed work the National Alliance of Sickle Cell Centers is conducting.
Julie Kanter, MD, on Preparing for Anticipated Approval of Lovo-Cel for Sickle Cell
The director of the Adult Sickle Cell Clinic and associate professor at University of Alabama Birmingham discussed the anticipated approval of the first gene therapy for SCD.
Julie Kanter, MD, on Lessons Learned With Investigating Lovo-Cel for SCD
The director of the Adult Sickle Cell Clinic and associate professor at University of Alabama Birmingham discussed her experiences serving as an investigator for lovo-cel clinical trials.